Join us for an exclusive webinar featuring leading experts in antimicrobial development as they present success stories in research on novel antibiotics and innovative antibacterial approaches!
You will learn:
– The latest breakthroughs in tackling multidrug-resistant Gram-negative bacteria.
– The development of endolysins—from concept to first-in-human trials.
– Key scientific insights, successes, and challenges shaping the future of antimicrobial development.

Time:
March 5, 15:00 – 16:30 CET

Speakers:
Douglas Huseby, PhD
– Researcher and ENABLE-2 Program Manager, Uppsala University

Dr. Lorenzo Corsini
– Managing Director, BioNTech R&D Austria

Dr. Michael Graz
– CEO of Disperazol Pharma ApS, Denmark
– CSO of Biophys Limited, UK
– Research Fellow, Costerton Biofilm Center, University of Copenhagen

Moderator:
Frederik Deroose, CEO, Connecting Pharma

Register for the webinar by clicking this link or pasting https://limesurvey.biocom.de/index.php/458174?lang=en in the browser.